Anesthetic Management of an Infant with Nesidioblastosis: A case report.
10.4097/kjae.1997.32.6.1031
- Author:
Duck Kyoung KIM
1
;
Jae Hyon BAHK
;
Jong Sung KIM
;
Seong Won MIN
Author Information
1. Department of Anesthesiology, College of Medicine, Seoul National University, Seoul, Korea.
- Publication Type:Case Report
- Keywords:
Metabolism;
hyperinsulinism;
nesidioblastosis;
Surgery;
near total pancreatectomy
- MeSH:
Apnea;
Congenital Hyperinsulinism;
Diagnosis;
Epithelium;
Humans;
Hyperinsulinism;
Hyperplasia;
Hypoglycemia;
Infant*;
Insulin;
Intellectual Disability;
Islets of Langerhans;
Lethargy;
Metabolism;
Muscle Hypotonia;
Nesidioblastosis*;
Pancreatectomy;
Plasma;
Seizures
- From:Korean Journal of Anesthesiology
1997;32(6):1031-1035
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Nesidioblastosis, persistent hyperinsulinemic hypoglycemia of infancy (PHHI) is a disorder characterized by diffuse pancreatic islet cell hyperplasia arising from the ductal epithelium. Patients usually present during the neonatal or infantile period with apnea, hypotonia, poor feeding, lethargy, or seizure. Despite of greater awareness, one in three has some degree of mental retardation by the time the diagnosis is made. The diagnosis is established by demonstrating high plasma insulin concentration during an episode of hypoglycemia. This hypoglycemia is initially managed medically, but these medical treatment modalities are failed in more than half of nesidioblastosis. Patient who failed to respond to optimal medical treatment should be referred for surgery early, if permanent neurologic damage is to be avoided. The surgical procedure of choice is near total pancreatectomy (95~98% resection). We herein discuss the anesthetic management of a patient with nesidioblastosis who presented for near total pancreatectomy.
